Erste Asset Management’s Edwards Lifesciences EW Stock Holding History

Erste Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.76M	Buy	41,251 +10,032	+32%	+$840K	0.03%	315
2026 Q1	$2.48M	Buy	31,219 +6,599	+27%	+$544K	0.02%	342
2025 Q4	$2.14M	Buy	24,620 +3,100	+14%	+$254K	0.02%	345
2025 Q3	$1.66M	Sell	21,520 -22,016	-51%	-$1.72M	0.02%	362
2025 Q2	$3.39M	Buy	43,536 +23,716	+120%	+$1.77M	0.03%	322
2025 Q1	$1.41M	Buy	19,820 +326	+2%	+$23.3K	0.02%	345
2024 Q4	$1.47M	Hold	19,494	–	–	0.02%	352
2024 Q3	$1.3M	Sell	19,494 -145,848	-88%	-$10.6M	0.02%	363
2024 Q2	$15.3M	Sell	165,342 -26,961	-14%	-$2.39M	0.2%	122
2024 Q1	$18.4M	Hold	192,303	–	–	0.25%	101
2023 Q4	$14.7M	Buy	192,303 +20,360	+12%	+$1.42M	0.22%	119
2023 Q3	$12M	Buy	171,943 +52,679	+44%	+$4.23M	0.21%	123
2023 Q2	$11M	Buy	119,264 +66,878	+128%	+$5.81M	0.19%	133
2023 Q1	$4.27M	Buy	52,386 +2,100	+4%	+$165K	0.08%	227
2022 Q4	$3.78M	Sell	50,286 -97,802	-66%	-$7.54M	0.08%	231
2022 Q3	$12.4M	Buy	148,088 +6,600	+5%	+$635K	0.28%	102
2022 Q2	$13.6M	Buy	141,488 +1,408	+1%	+$146K	0.3%	93
2022 Q1	$16.4M	Sell	140,080 -4,180	-3%	-$469K	0.31%	87
2021 Q4	$18.8M	Sell	144,260 -49,390	-26%	-$5.76M	0.34%	86
2021 Q3	$22M	Buy	193,650 +38,470	+25%	+$4.39M	0.44%	71
2021 Q2	$16.1M	Sell	155,180 -600	-0.4%	-$56.6K	0.32%	88
2021 Q1	$12.9M	Sell	155,780 -42,750	-22%	-$3.61M	0.32%	96
2020 Q4	$17.9M	Buy	198,530 +2,700	+1%	+$224K	0.49%	57
2020 Q3	$15.3M	Buy	195,830 +27,200	+16%	+$2.12M	0.52%	62
2020 Q2	$11.4M	Buy	168,630 +31,260	+23%	+$2.22M	0.46%	60
2020 Q1	$8.98M	Sell	137,370 -1,200	-0.9%	-$86.5K	0.52%	55
2019 Q4	$10.8M	Buy	138,570 +9,000	+7%	+$703K	0.48%	55
2019 Q3	$9.38M	Sell	129,570 -14,100	-10%	-$990K	0.5%	53
2019 Q2	$8.88M	Buy	143,670 +26,100	+22%	+$1.58M	0.47%	55
2019 Q1	$7.4M	Sell	117,570 -1,830	-2%	-$104K	0.41%	56
2018 Q4	$5.97M	Buy	+119,400	New	+$6.04M	0.4%	58

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Erste Asset Management's EW Position: Q2 2026 in Review

Erste Asset Management increased its Edwards Lifesciences (EW) stake by 32% in Q2 2026, buying an estimated $840K and bringing the position to 41,251 shares worth $3.76M. The position accounts for 0.03% of the portfolio, ranked #315.

Erste Asset Management first reported a position in EW in Q4 2018 and has held it in 31 quarters since. The position peaked at $22M in Q3 2021. 1,330 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Erste Asset Management held 41,251 shares of Edwards Lifesciences worth $3.76M as of Q2 2026.
Erste Asset Management bought 10,032 Edwards Lifesciences shares in Q2 2026, an estimated $840K.
Edwards Lifesciences made up 0.03% of Erste Asset Management's portfolio in Q2 2026, its #315 holding.
Erste Asset Management first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 31 quarters since.
Erste Asset Management's Edwards Lifesciences position peaked at $22M in Q3 2021.
1,330 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.